Marker (samples) | Adjusted Risk (%) | Adjusted RD (95% CI) | Interaction Contrast (95% CI) |
---|---|---|---|
Gastrointestional illness b | |||
– |  | 1.4% (0.6%, 2.3%) |  |
HumM2 | |||
0–1 | 4.4 | Ref |  |
 | 6.3 | 1.8% (1.0%, 2.7%) |  |
≥2 | 5.9 | Ref |  |
 | 6.9 | 1.0% (−0.5%, 2.4%) | −0.9% (−2.3%, 0.6%) |
HF183 | |||
0–1 | 4.4 | Ref |  |
 | 6.1 | 1.7% (0.6%, 2.7%) |  |
≥2 | 5.7 | Ref |  |
 | 6.9 | 1.3% (0.2%, 2.4%) | −0.4% (−1.7%, 0.9%) |
BsteriF1 | |||
0–1 | 7.2 | Ref |  |
 | 7.2 | 0.0% (−3.7%, 3.7%) |  |
≥2 | 5.6 | Ref |  |
 | 7.0 | 1.4% (0.4%, 2.4%) | 1.4% (−2.4%, 5.1%) |
BuniF2 | |||
0–1 | 1.1 | Ref |  |
 | 2.5 | 1.5% (0.4%, 2.5%) |  |
≥2 | 5.7 | Ref |  |
 | 7.0 | 1.3% (0.3%, 2.3%) | −0.2% (−1.5%, 1.1%) |
Diarrhea b | |||
– |  | 1.1% (0.6%, 1.7%) |  |
HumM2 | Â | Â | Â |
0–1 | 2.6 | Ref |  |
 | 4.0 | 1.4% (0.9%, 1.9%) |  |
≥2 | 3.3 | Ref |  |
 | 4.2 | 0.9% (0.0%, 1.8%) | −0.5% (−1.4%, 0.4%) |
HF183 | |||
0–1 | 3.6 | Ref |  |
 | 4.8 | 1.2% (0.1%, 2.3%) |  |
≥2 | 2.7 | Ref |  |
 | 3.9 | 1.2% (0.7%, 1.7%) | 0.0% (−1.1%, 1.1%) |
BsteriF1 | |||
0–1 | 5.5 | Ref |  |
 | 5.2 | −0.3% (−4.0%, 3.5%) |  |
≥2 | 3.0 | Ref |  |
 | 4.2 | 1.2% (0.7%, 1.7%) | 1.5% (−2.3%, 5.2%) |
BuniF2 | |||
0–1 | 0.9 | Ref |  |
 | 2.1 | 1.2% (0.3%, 2.1%) |  |
≥2 | 3.2 | Ref |  |
 | 4.3 | 1.1% (0.5%, 1.7%) | −0.1% (−1.1%, 0.9%) |
Respiratory Illness c | |||
– |  | 0.6% (−0.7%, 1.8%) |  |
HumM2 | |||
0–1 | 6.4 | Ref |  |
 | 6.4 | 0.0% (−2.0%, 2.0%) |  |
≥2 | 4.6 | Ref |  |
 | 5.6 | 1.0% (−0.4%, 2.3%) | 0.9% (−1.2%, 3.1%) |
HF183 | |||
0–1 | 13.9 | Ref |  |
 | 9.5 | −4.4% (−10.8%, 2.0%) |  |
≥2 | 3.9 | Ref |  |
 | 5.1 | 1.3% (0.4%, 2.1%) | 5.7% (−0.7%, 12%) |
BsteriF1 | |||
0–1 | 8.7 | Ref |  |
 | 6.7 | −1.9% (−7.8%, 4.0) |  |
≥2 | 5.7 | Ref |  |
 | 6.2 | 0.5% (−0.9%, 1.9%) | 2.5% (−3.3%, 8.3%) |
BuniF2 | Â | Â | Â |
0–1 | 1.5 | Ref |  |
 | 2.7 | 1.2% (0.7%, 1.8%) |  |
≥2 | 5.6 | Ref |  |
 | 6.1 | 0.5% (−0.9%, 1.8%) | −0.8% (−2.1%, 0.5%) |